Published in Hypertension on August 01, 1997
β1-Blockers Lower Norepinephrine Release by Inhibiting Presynaptic, Facilitating β1-Adrenoceptors in Normotensive and Hypertensive Rats. Front Neurol (2014) 0.83
Primary prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with end-stage renal disease undergoing dialysis. Kidney Int (2015) 0.82
Upregulation of tachykinin NK-1 and NK-3 receptor binding sites in the spinal cord of spontaneously hypertensive rat: impact on the autonomic control of blood pressure. Br J Pharmacol (2006) 0.80
The thermoluminescence dose-response and other characteristics of the high-temperature TL in LiF:Mg,Ti (TLD-100). Radiat Prot Dosimetry (2007) 2.07
N-terminal proatrial natriuretic factor. An independent predictor of long-term prognosis after myocardial infarction. Circulation (1994) 2.05
Sildenafil (Viagra) prolongs cardiac repolarization by blocking the rapid component of the delayed rectifier potassium current. Circulation (2000) 1.91
Treatment of microalbuminuria in hypertensive subjects with elevated cardiovascular risk: results of the IMPROVE trial. Kidney Int (2007) 1.67
Two-year time course and significance of neurohumoral activation in the Survival and Ventricular Enlargement (SAVE) Study. Eur Heart J (1998) 1.52
Cycle length dynamics at the onset of postinfarction ventricular tachycardias induced in canines: dependence on interval-dependent excitation properties of the reentrant substrate. J Cardiovasc Electrophysiol (2000) 1.48
The serum porphobilinogen and hepatic porphobilinogen deaminase in normal and porphyric individuals. J Lab Clin Med (1971) 1.47
Regulation of norepinephrine release from cardiac sympathetic fibers in the dog by presynaptic alpha- and beta-receptors. Circ Res (1977) 1.37
Circulating catecholamine levels in human and experimental hypertension. Circ Res (1976) 1.37
Domperidone should not be considered a no-risk alternative to cisapride in the treatment of gastrointestinal motility disorders. Circulation (2000) 1.33
Repression of the overproduction of porphyrin precursors in acute intermittent porphyria by intravenous infusions of hematin. Proc Natl Acad Sci U S A (1971) 1.33
Epicardial and endocardial mapping of ventricular tachycardia in patients with myocardial infarction. Is the origin of the tachycardia always subendocardially localized? Circulation (1991) 1.25
Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: effect of captopril. J Am Coll Cardiol (1994) 1.24
Dysfunction of the beta- and alpha-adrenergic systems in a model of congestive heart failure. The pacing-overdrive dog. Circ Res (1991) 1.22
Influence of respiration on heart rate and blood pressure fluctuations. J Appl Physiol (1985) (1993) 1.19
Effect of hematin in acute porphyric relapse. Ann Intern Med (1973) 1.19
Transitory renal failure following rapid administration of a relatively large amount of hematin in a patient with acute intermittent porphyria in clinical remission. Acta Med Scand (1978) 1.17
Catecholamine metabolism in experimental hypertension in the rat. Circ Res (1967) 1.17
Effects of hematin in hepatic porphyria. Further studies. Ann Intern Med (1975) 1.14
Supersensitivity of the isolated rat heart after chemical sympathectomy with 6-hydroxydopamine. Can J Physiol Pharmacol (1971) 1.10
Correlation between the response of the heart to sympathetic stimulation and the release of endogenous catecholamines into the coronary sinus of the dog. Circ Res (1975) 1.09
Use of hematin in the acute attack of the "inducible" hepatic prophyrias. Adv Intern Med (1978) 1.07
Enhanced superoxide anion formation in vascular tissues from spontaneously hypertensive and desoxycorticosterone acetate-salt hypertensive rats. J Hypertens (2001) 1.05
Catecholamines in coronary sinus during exercise in man before and after training. J Appl Physiol Respir Environ Exerc Physiol (1977) 1.04
Cardiac responses to electrical stimulation of discrete loci in canine atrial and ventricular ganglionated plexi. Am J Physiol (1990) 1.04
A reduction in the accumulation of H3-norepinephrine in experimental hypertension. Life Sci (1966) 1.03
Impaired basal sympathetic tone and alpha1-adrenergic responsiveness in association with the hypotensive effect of melatonin in spontaneously hypertensive rats. Am J Hypertens (1998) 0.97
The effects of ionisation density on the glow curve structure of LiF:Mg,Ti (TLD-100): the behaviour of composite glow peak 5 in 'slow-cooled' material. Radiat Prot Dosimetry (2007) 0.97
Advanced multistage deconvolution applied to composite glow peak 5 in LiF:Mg,Ti (TLD-100). Radiat Prot Dosimetry (2007) 0.96
Increased plasma catecholamine levels in patients with symptomatic mitral valve prolapse. Am J Med (1982) 0.96
The heart reinnervates after transplantation. Ann Thorac Surg (2000) 0.95
Stability of delta-aminolevulinic acid and porphobilinogen in urine under varying conditions. Clin Chem (1968) 0.95
Activation of neurohumoral systems in postinfarction left ventricular dysfunction. J Am Coll Cardiol (1993) 0.95
Postulated deficiency of hepatic heme and repair by hematin infusions in the "inducible" hepatic porphyrias. Proc Natl Acad Sci U S A (1977) 0.93
Negative inotropic and chronotropic effects of oxytocin. Hypertension (2001) 0.93
Inhibition by cyclic AMP of basal and induced inositol phosphate production in cultured aortic smooth muscle cells from Wistar-Kyoto and spontaneously hypertensive rats. J Hypertens (1996) 0.92
Plasma norepinephrine response to exercise before and after training in humans. J Appl Physiol Respir Environ Exerc Physiol (1981) 0.92
Abnormal storage of norepinephrine in experimental hypertension in the rat. Circ Res (1967) 0.91
Cardiovascular effects of Buthus martensii (Karsch) scorpion venom. Toxicon (1994) 0.91
The 6Fr Angio-Seal arterial closure device: results from a multimember prospective registry. Am J Cardiol (2001) 0.90
Degeneration and regrowth of adrenergic nerve fibers in the rat peripheral tissues after 6-hydroxydopamine. Can J Physiol Pharmacol (1971) 0.90
Regional distribution of atrial electrical changes induced by stimulation of extracardiac and intracardiac neural elements. J Thorac Cardiovasc Surg (1995) 0.90
Markedly different effects on ventricular remodeling result in a decrease in inducibility of ventricular arrhythmias. J Am Coll Cardiol (1994) 0.89
The clinical evaluation of hypertension. Can Fam Physician (1985) 0.89
Effects of Buthus martensii Karsch scorpion venom on the release of noradrenaline from in vitro and in vivo rat preparations. Can J Physiol Pharmacol (1994) 0.89
Repression by hematin of porphyrin biosynthesis in erythrocyte precursors in congenital erythropoietic porphyria. Proc Natl Acad Sci U S A (1974) 0.89
Effects of 6-hydroxydopamine on the canine sinus node. Circ Res (1971) 0.88
Vascular calcium overload produced by administration of vitamin D3 and nicotine in rats. Changes in tissue calcium levels, blood pressure, and pressor responses to electrical stimulation or norepinephrine in vivo. J Cardiovasc Pharmacol (1990) 0.88
Plasma catecholamines in acute myocardial infarction. Am Heart J (1979) 0.88
Overexpression of Gi-proteins precedes the development of DOCA-salt-induced hypertension: relationship with adenylyl cyclase. Cardiovasc Res (1998) 0.88
Experimental investigation of the 100 keV X-ray dose response of the high-temperature thermoluminescence in LiF:Mg,Ti (TLD-100): theoretical interpretation using the unified interaction model. Radiat Prot Dosimetry (2009) 0.87
Hematin therapy in porphyric attacks. Klin Wochenschr (1980) 0.87
Effects of chronic N-acetylcysteine treatment on the actions of peroxynitrite on aortic vascular reactivity in hypertensive rats. J Hypertens (2001) 0.86
The effects of lidocaine on intracellular and extracellular potentials, activation, and ventricular arrhythmias during acute regional ischemia in the isolated porcine heart. Circ Res (1981) 0.86
Termination of sustained ventricular tachycardia by ultrarapid subthreshold stimulation in humans. Circulation (1988) 0.86
The sympathetic system in hypertension. Clin Endocrinol Metab (1977) 0.85
The kinin B1 receptor antagonist SSR240612 reverses tactile and cold allodynia in an experimental rat model of insulin resistance. Br J Pharmacol (2007) 0.85
Increased plasma catecholamines in patients with Friedreich's ataxia. Can J Neurol Sci (1982) 0.85
Abnormal regulation of cytosolic free calcium in vascular endothelial cells from spontaneously hypertensive rats. J Hypertens (1995) 0.85
Effects of atenolol and hydrochlorothiazide on blood pressure and plasma catecholamines in essential hypertension. Hypertension (1983) 0.84
Hematin treatment of acute porphyria. Early remission of an almost fatal relapse. JAMA (1976) 0.84
Sympathoadrenal mechanisms underlying cardiovascular responses to intrathecal substance P in conscious rats. J Cardiovasc Pharmacol (1990) 0.84
Increased apparent norepinephrine release rate in anesthetized DOCA-salt hypertensive rats. Clin Exp Hypertens A (1985) 0.84
Functional desensitization to isoproterenol without reducing cAMP production in canine failing cardiocytes. Am J Physiol Regul Integr Comp Physiol (2001) 0.84
Evidences supporting an increased sympathetic tone and reactivity in a subgroup of patients with essential hypertension. Clin Exp Hypertens (1980) 0.84
Clinical applications of BSM. J Electrocardiol (1995) 0.84
Mapping of ventricular tachycardia induced by programmed stimulation in canine preparations of myocardial infarction. Circulation (1984) 0.83
Electrophysiological effects of bretylium tosylate on subendocardial Purkinje fibers from infarcted canine hearts. J Pharmacol Exp Ther (1978) 0.83
On the use of LiF:Mg,Ti thermoluminescence dosemeters in space--a critical review. Radiat Prot Dosimetry (2003) 0.83
Protective effects of ceruloplasmin against electrolysis-induced oxygen free radicals in rat heart. Can J Physiol Pharmacol (1991) 0.83
Polymorphic ventricular tachycardias induced by D-sotalol and phenylephrine in canine preparations of atrioventricular block: initiation in the conduction system followed by spatially unstable re-entry. Cardiovasc Res (1998) 0.82
Mysteries of LiF TLD response following high ionisation density irradiation: nanodosimetry and track structure theory, dose response and glow curve shapes. Radiat Prot Dosimetry (2010) 0.82
Alteration of prejunctional alpha 2-adrenergic autoinhibition in DOCA-salt hypertension. Am J Hypertens (1995) 0.82
Effect of chronic ANG I-converting enzyme inhibition on aging processes. V. Intracellular calcium-vasoreactivity coupling. Am J Physiol (1995) 0.82
The development of sympathetic innervation and the functional state of the cardiovascular system in newborn dogs. Can J Physiol Pharmacol (1975) 0.82
Alpha particle and proton relative thermoluminescence efficiencies in LiF:Mg,Cu,P:is track structure theory up to the task? Radiat Prot Dosimetry (2011) 0.82
Muscarinic inhibition of endogenous myocardial catecholamine liberation in the dog. Can J Physiol Pharmacol (1978) 0.82
Subcellular localization of monoamine oxidase in rat tissues. J Pharmacol Exp Ther (1969) 0.82
Neurohumoral and hemodynamic changes in congestive heart failure: lack of correlation and evidence of compensatory mechanisms. Am Heart J (1988) 0.81
Cardiovascular and sympathoadrenal responses to intrathecal injection of neuropeptide K in the conscious rat. Naunyn Schmiedebergs Arch Pharmacol (1993) 0.81
Intracellular free Ca2+ and vasoconstriction determined simultaneously in the perfused rat tail artery. Am J Physiol (1993) 0.81
Plasma norepinephrine, epinephrine, and dopamine beta-hydroxylase activity during exercise in man. Med Sci Sports Exerc (1985) 0.81
Norepinephrine and serotonin increase the vasoconstrictor response of the perfused rat tail artery to changes in cytosolic Ca2+. Eur J Pharmacol (1990) 0.81
Relationship between an arrhythmogenic action of lidocaine and its effects on excitation patterns in acutely ischemic porcine myocardium. J Cardiovasc Pharmacol (1986) 0.80
The intracortical distribution of norepinephrine, dopamine and serotonin in the cerebral cortex of the cat. Brain Res (1979) 0.80
Vasovagal syncope: management with atrioventricular sequential pacing and beta-blockade. Can J Cardiol (1990) 0.80
Characterisation of unipolar waveform alternation in acutely ischaemic porcine myocardium. Cardiovasc Res (1986) 0.80
Body surface potential distributions during idiopathic ventricular tachycardia. Circulation (1995) 0.80
Myocardial dysfunction and norepinephrine release in the isolated rat heart injured by electrolysis-induced oxygen free radicals. J Mol Cell Cardiol (1991) 0.80
Catecholamine release and ventricular arrhythmias during coronary occlusion and reperfusion in the dog. Can J Physiol Pharmacol (1985) 0.80
Effect of hematin in porphyric neuropathy. Neurology (1977) 0.80
Norepinephrine-induced aortic hyperplasia and extracellular matrix deposition are endothelin-dependent. J Hypertens (2001) 0.80
Thermoluminescence solid-state nanodosimetry--the peak 5A/5 dosemeter. Radiat Prot Dosimetry (2010) 0.80
QT interval prolongation and increased plasma catecholamine levels in patients with mitral valve prolapse. Am Heart J (1983) 0.80
Surgical treatment of ventricular tachycardia. Regional cryoablation guided by computerized epicardial and endocardial mapping. Circulation (1989) 0.80
The activities of uroporphyrinogen synthetase and cosynthetase in congenital erythropoietic porphyria (CEP). Am J Hematol (1976) 0.79
Beta 1- and beta 2-adrenoceptor subtypes in canine intrathoracic efferent sympathetic nervous system regulating the heart. Am J Physiol (1991) 0.79